MediSieve
Alina Kagermazova began their work experience in 2015 as a Finance Intern at Avon. In 2016, they continued their internship as a Finance Intern at Inter RAO. In 2017, they worked as an Analyst for the 2018 FIFA World Cup team at Strelka KB. In 2018, Alina worked as a Consultant at todogood - Social Changes Platform. Alina then joined MediSieve in 2019, starting as a Marketing Intern and later progressing to roles such as Marketing Analyst, Marketing and Business Development Analyst, Marketing and Business Development Manager, and currently, serves as the Head of Business Development.
Alina Kagermazova completed their education in a chronological order. Alina started by earning a Bachelor's degree in Economics from the Higher School of Economics in the years 2013 to 2017. Following that, they pursued another Bachelor's degree, this time in Economics and Finance, at the University of London from 2014 to 2017. Lastly, they went on to pursue a Master's degree at the London Business School from 2018 to 2019. No specific field of study was mentioned for their Master's degree.
This person is not in any teams
MediSieve
1 followers
MediSieve is a multi-award-winning medical device company developing Magnetic Blood Filtration (MBF), a platform technology for the treatment of blood-borne diseases by physically removing disease relevant targets directly from a patient’s bloodstream. MBF is an extracorporeal technology, similar to dialysis. A patient's blood is continuouslycirculated through an external blood loop containing the MediSieve system. Targeted magnetic particles (TB-MPs) are infused into the loop, binding specifically to disease-relevant targets in the patient's blood. The blood then flows through a magnetic filter which captures the particles and bound targets and the remainder of the blood returns to the patient unaffected; the TB-MPs never enter the patient’s body.MediSieve is based at the Imperial Incubator in White City, London. It has dedicated workshop and laboratory facilities (including capacity for ELISAs, Flow Cytometry and human blood testing) in which products are developed and validated.